According to existing research, fucoidan slows the growth of cancer by interacting with growth factors such as transforming growth factor beta (TGF- β), vascular endothelial growth factor (VEGF), bone morphogenetic protein (BMP), and estrogen receptor and caspase pathways (van Weelden et al., 2019). The gene discussed is VEGFA; the disease is cancer.